Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.

BMC Biotechnol · 2012 · PMC3505484 · PMID 23006786

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

at the limit of significanceno p-value reported

However, IL-1ra treatment showed only a little protection, and often the data were not significant or at the limit of significance, probably due to an insufficient dosage and a relatively long injection interval.

also in 326 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.